Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) - New Report by Azoth Analytics

1
Global Alzheimers Drug Market Trends,
Opportunities and Forecasts (2015-2020)
December 2015
1
2
Table of Content
Figure No. Title Title Title Title Page No.
1 Research Methodology Research Methodology Research Methodology Research Methodology
2 Alzheimers Disease Market Overview Alzheimers Disease Market Overview Alzheimers Disease Market Overview Alzheimers Disease Market Overview
3 Global Alzheimers Disease Market Outlook Global Alzheimers Disease Market Outlook Global Alzheimers Disease Market Outlook Global Alzheimers Disease Market Outlook
4 Global Alzheimers Disease Market Global Alzheimers Disease Market Global Alzheimers Disease Market Global Alzheimers Disease Market
4.1 By Therapeutics By Therapeutics By Therapeutics
4.2 By Diagnostics and Biomarkers By Diagnostics and Biomarkers By Diagnostics and Biomarkers
4.3 By Imaging Sector By Imaging Sector By Imaging Sector
4.4 By Disease Modifying Therapeutics By Disease Modifying Therapeutics By Disease Modifying Therapeutics
5 Global Alzheimers Disease Market Outlook-By Demographic (Age-Group) Global Alzheimers Disease Market Outlook-By Demographic (Age-Group) Global Alzheimers Disease Market Outlook-By Demographic (Age-Group) Global Alzheimers Disease Market Outlook-By Demographic (Age-Group)
6 Global Alzheimers Disease Market Outlook-By Drug Global Alzheimers Disease Market Outlook-By Drug Global Alzheimers Disease Market Outlook-By Drug Global Alzheimers Disease Market Outlook-By Drug
6 Global Alzheimers Disease Market Outlook-By Region Global Alzheimers Disease Market Outlook-By Region Global Alzheimers Disease Market Outlook-By Region Global Alzheimers Disease Market Outlook-By Region
7 United States Alzheimers Disease Market Outlook United States Alzheimers Disease Market Outlook United States Alzheimers Disease Market Outlook United States Alzheimers Disease Market Outlook
7.1 United States Dementia Market Outlook United States Dementia Market Outlook United States Dementia Market Outlook
8 Global Dementia Disease Market Outlook Global Dementia Disease Market Outlook Global Dementia Disease Market Outlook Global Dementia Disease Market Outlook
9 Global Dementia Disease Market Outlook, Global Dementia Disease Market Outlook, Global Dementia Disease Market Outlook, Global Dementia Disease Market Outlook,
9.1 By Regional Break-Up By Regional Break-Up By Regional Break-Up
9.1.1 Asia-Pacific Dementia Market Outlook Asia-Pacific Dementia Market Outlook
9.1 By Countries By Countries By Countries
9.2.2 Low Income Country -wise Break up
9.2.3 Top Ten Country-wise Break-Up
2
3
Table of Content
Figure No. Title Title Page No.
9.3 Australia Dementia Market Outlook
9.4 UK Dementia Market Outlook
10 Market Dynamics Market Dynamics
10.1 Drivers
10.2 Challenges
11 Market Trends Developments Market Trends Developments
12 Competitive Landscape Competitive Landscape
12.2 Sales Comparatives, Top 5 Companies
12.3 EBITDA Comparatives, Top 5 Companies
12.4 EBIT Comparatives, Top 5 Companies
12.5 PBT Comparatives, Top 5 Companies
12.6 PAT Comparatives, Top 5 Companies
12.7 Current Ratio Comparatives, Top 5 Companies
12 Company Profiling Company Profiling
Pfizer Inc.
Novartis International AG
Axovant Sciences Ltd.
Acadia Pharmaceuticals
Biotie Therapies
3
4
Table of Content
Figure No. Title Title Page No.
12.8 Profit Margin Ratio Comparatives, Top 5 Companies
12.9 Debt-Equity Ratio Comparatives, Top 5 Companies
13 About Us Disclaimer About Us Disclaimer
4
5
List of Figures
Figure No. Title Page No.
Figure 1 Global Alzheimers Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
Figure 2 Global Alzheimers Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
Figure 3 Global Alzheimers Market share, By Therapeutics
Figure 4 Global Alzheimers Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
Figure 5 Global Alzheimers Disease Market, By Imaging Sector, By Value (USD Million)x
Figure 6 Global Alzheimers Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
Figure 7 Global Alzheimers Disease Market, By Demographics, By Age lt 65, By Volume (Number of patients in million),2010-2020F
Figure 8 Global Alzheimers Disease Market, By Demographics, By Age gt 65, By Volume (Number of patients in million),2010-2020F
Figure 9 Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
Figure 10 United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
Figure 11 Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
Figure 12 U.S. Alzheimers Drug RTV-101 Market , By Value Penetration Rate 2019-2027 (USD Million)
Figure 13 U.S. Alzheimers Drug Azeliragon Market, By Value Penetration Rate, 2019-2027 (USD Million)
Figure 14 U.S. Annual Alzheimers Death Rates ,By Age 2006-2013
Figure 15 U.S. Annual Alzheimers Death Rates ,By Age 2006-2013
5
6
List of Figures
Figure No. Title Page No.
Figure 16 Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
Figure 17 Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
Figure 18 Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
Figure 19 Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
Figure 20 Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
Figure 21 Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
Figure 22 Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
Figure 23 Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
Figure 24 Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
Figure 25 Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
Figure 26 UK Dementia Market, By Type, 2014 ()
Figure 27 UK Dementia Cost, By Type of Service, 2014 ()
Figure 28 Number of Unpaid Caregivers (In Million)
Figure 29 Pfizer Revenue (USD Million) AY 2011-2014
Figure 30 Pfizer Percentage Revenue, By Business Segment (2014)
Figure 31 Pfizer Percentage Revenue, By Geography (2014)
6
7
List of Figures
Figure No. Title Page No.
Figure 32 Novartis International AG Revenue (USD Million) AY 2011-2014
Figure 33 Novartis International AG Percentage Revenue, By Business Segment (2014)
Figure 34 Novartis International AG Percentage Revenue, By Geography (2014)
Figure 35 Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
Figure 36 Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
Figure 37 Axovant Services Ltd. Percentage Revenue, By Geography (2014)
Figure 38 Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
Figure 39 Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
Figure 40 Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
Figure 41 Biotie Therapies Revenue (USD Million) AY 2011-2014
Figure 42 Biotie Therapies Percentage Revenue, By Business Segment (2014)
Figure 43 Sales Comparatives, Top 5 Companies, 2011-2014
Figure 44 EBITDA Comparatives, Top 5 Companies, 2011-2015
Figure 45 EBIT Comparatives, Top 5 Companies, 2011-2015
Figure 46 PBT Comparatives, Top 5 Companies, 2011-2015
Figure 47 PAT Comparatives, Top 5 Companies, 2011-2015
Figure 48 Current Ratio Comparatives, Top 5 Companies, 2011-2015
Figure 49 Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
Figure 50 Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
7
8
Research Methodology
Azoth Analytics has conducted quantitative as
well as qualitative research to gather market
insights such as market sizing, market
segmentation, recent trends and developments and
competitive landscape. Our team has conducted
extensive primary surveys by reaching out
industry experts across the Alzheimers disease
market. For Forecasting purposes, we have
accessed some of the paid databases such as
Bloomberg, Reuters, Factiva, and Hoovers.
Companies Contacted Pfizer Inc., Novartis
International AG, Axovant Sciences Ltd.,Acadia
Pharmaceuticals, Biotie Therapies
8
9
Alzheimers Disease Market Overview
9
10
Alzheimers Disease Market Overview
10
11
Alzheimers Disease Market Overview
11
12
Alzheimers Disease Market Overview
12
13
Alzheimers Disease Market Overview
13
14
Alzheimers Disease Market Overview
14
15
Global Alzheimers Drug Market Trends,
Opportunities and Forecasts (2015-2020) (By Type
- Imaging, Therapeutics, Diagnostics, Biomarkers
By Age lt65 years, gt65 years age By Region
Global Dementia Market) Number of Pages
106 Price US 2000 (Single User) Price US 3000
(Multi-User) Order Online http//www.azothanaly
tics.com/report/global-alzheimerE28099s-drug-ma
rket-trends-opportunities-and-forecasts-2015-2020-
r4 Contact Details Contact Person Subhodeep
Sen E-mail info_at_azothanalytics.com Phone Number
Tel [phone] Helpline Number 91
9873 4262 88 About Azoth Analytics Pvt
Ltd. Our business research and market analysis
helps organizations across different industry
verticals solve their business problems. In our
reports, historic market trend is figured out by
various paid databases which is further
triangulated with inputs and insights from
industry experts through primary research.
Back-of-the-Envelope calculation for the market
estimation is being made through proper
understanding of the market as well as future
business strategies of the companies engaged in
the market. Our detailed research reports help
our clients and customers get clear understanding
of a specific industry or vertical of a
designated country or region and make informed
decision pertaining to market entry or expansion,
strategic alliances or partnerships, product
launch or brand positioning.
15